Qiqilian ameliorates vascular endothelial dysfunction by inhibiting NLRP3-ASC inflammasome activation in vivo and in vitro

References

• Bal NB, Bostanci A, Sadi G, Donmez MO, Uludag MO, Demirel-Yilmaz E. 2022. Resveratrol and regular exercise may attenuate hypertension-induced cardiac dysfunction through modulation of cellular stress responses. Life Sci. 296:120424.
   PubMed Web of Science ®Google Scholar
• Baumbach GL, Heistad DD. 1989. Remodeling of cerebral arterioles in chronic hypertension. Hypertension. 13(6 Pt 2):968–972.
   PubMed Web of Science ®Google Scholar
• Bian F, Cui J, Zheng T, Jin S. 2017. Reactive oxygen species mediate angiotensin II-induced transcytosis of low-density lipoprotein across endothelial cells. Int J Mol Med. 39(3):629–635.
   PubMed Web of Science ®Google Scholar
• Denton D, Xu T, Kumar S. 2015. Autophagy as a pro-death pathway. Immunol Cell Biol. 93(1):35–42.
   PubMed Web of Science ®Google Scholar
• Deretic V, Saitoh T, Akira S. 2013. Autophagy in infection, inflammation and immunity. Nat Rev Immunol. 13(10):722–737.
   PubMed Web of Science ®Google Scholar
• Dharmashankar K, Widlansky ME. 2010. Vascular endothelial function and hypertension: insights and directions. Curr Hypertens Rep. 12(6):448–455.
   PubMed Web of Science ®Google Scholar
• Dimmeler S, Rippmann V, Weiland U, Haendeler J, Zeiher AM. 1997. Angiotensin II induces apoptosis of human endothelial cells. Protective effect of nitric oxide. Circ Res. 81(6):970–976.
   PubMed Web of Science ®Google Scholar
• Fei YX, Zhao B, Yin QY, Qiu YY, Ren GH, Wang BW, Wang YF, Fang WR, Li YM. 2019. Ma Xing Shi Gan decoction attenuates PM2.5 induced lung injury via inhibiting HMGB1/TLR4/NFkappaB signal pathway in rat. Front Pharmacol. 10:1361.
   PubMed Web of Science ®Google Scholar
• Hao P, Jiang F, Cheng J, Ma L, Zhang Y, Zhao Y. 2017. Traditional Chinese medicine for cardiovascular disease: evidence and potential mechanisms. J Am Coll Cardiol. 69(24):2952–2966.
   PubMed Web of Science ®Google Scholar
• Hao PP, Jiang F, Chen YG, Yang J, Zhang K, Zhang MX, Zhang C, Zhao YX, Zhang Y. 2015. Traditional Chinese medication for cardiovascular disease. Nat Rev Cardiol. 12(6):318.
   PubMedGoogle Scholar
• Hu R, Wang MQ, Ni SH, Wang M, Liu LY, You HY, Wu XH, Wang YJ, Lu L, Wei LB. 2020. Salidroside ameliorates endothelial inflammation and oxidative stress by regulating the AMPK/NF-kappaB/NLRP3 signaling pathway in AGEs-induced HUVECs. Eur J Pharmacol. 867:172797.
   PubMed Web of Science ®Google Scholar
• Huang PP, Fu J, Liu LH, Wu KF, Liu HX, Qi BM, Liu Y, Qi BL. 2020. Honokiol antagonizes doxorubicin-induced cardiomyocyte senescence by inhibiting TXNIPmediated NLRP3 inflammasome activation. Int J Mol Med. 45(1):186–194.
   PubMed Web of Science ®Google Scholar
• Kim KH, Lee MS. 2014. Autophagy–a key player in cellular and body metabolism. Nat Rev Endocrinol. 10(6):322–337.
   PubMed Web of Science ®Google Scholar
• Li H, Xiao L, He H, Zeng H, Liu J, Jiang C, Mei G, Yu J, Chen H, Yao P, et al. 2021. Quercetin attenuates atherosclerotic inflammation by inhibiting galectin-3-NLRP3 signaling pathway. Mol Nutr Food Res. 65(15):e2000746.
   PubMed Web of Science ®Google Scholar
• Li L, Tan J, Miao Y, Lei P, Zhang Q. 2015. ROS and autophagy: interactions and molecular regulatory mechanisms. Cell Mol Neurobiol. 35(5):615–621.
   PubMed Web of Science ®Google Scholar
• Liu D, Sun WP, Chen JW, Jiang Y, Xue R, Wang LH, Murao K, Zhang GX. 2021. Autophagy contributes to angiotensin II induced dysfunction of HUVECs. Clin Exp Hypertens. 43(5):462–473.
   PubMed Web of Science ®Google Scholar
• Liu D, Zeng X, Li X, Mehta JL, Wang X. 2018. Role of NLRP3 inflammasome in the pathogenesis of cardiovascular diseases. Basic Res Cardiol. 113(1):5.
   PubMed Web of Science ®Google Scholar
• Liu Q, Zhang D, Hu D, Zhou X, Zhou Y. 2018. The role of mitochondria in NLRP3 inflammasome activation. Mol Immunol. 103:115–124.
   PubMed Web of Science ®Google Scholar
• Long L, Yang X, Southwood M, Lu J, Marciniak SJ, Dunmore BJ, Morrell NW. 2013. Chloroquine prevents progression of experimental pulmonary hypertension via inhibition of autophagy and lysosomal bone morphogenetic protein type II receptor degradation. Circ Res. 112(8):1159–1170.
   PubMed Web of Science ®Google Scholar
• Luo Y, Yue GH, Yun YE, Lei FU. 2015. Protective effect of qiqilian capsule against left ventricular hypertrophy of spontaneously hypertensive rats. Chin J Exper Trad Med Form. 21:116–120.
   Google Scholar
• Mirabito Colafella KM, Danser AHJ. 2017. Recent advances in angiotensin research. Hypertension. 69(6):994–999.
   PubMed Web of Science ®Google Scholar
• NCD Risk Factor Collaboration (NCD-RisC). 2021. Worldwide trends in hypertension prevalence and progress in treatment and control from 1990 to 2019: a pooled analysis of 1201 population-representative studies with 104 million participants. Lancet. 398(10304):957–980.
   PubMed Web of Science ®Google Scholar
• Qin Y, Zhu Z, Zhang A, Yue G. 2013. Effect of Qiqilian capsule on life quality of hypertension patients. Jiangsu J Trad Chin Med. 45:25–27.
   Google Scholar
• Silva BR, Pernomian L, Bendhack LM. 2012. Contribution of oxidative stress to endothelial dysfunction in hypertension. Front Physiol. 3:441.
   PubMed Web of Science ®Google Scholar
• Sun C, Diao Q, Lu J, Zhang Z, Wu D, Wang X, Xie J, Zheng G, Shan Q, Fan S, et al. 2019. Purple sweet potato color attenuated NLRP3 inflammasome by inducing autophagy to delay endothelial senescence. J Cell Physiol. 234(5):5926–5939.
   PubMed Web of Science ®Google Scholar
• Sun HJ, Ren XS, Xiong XQ, Chen YZ, Zhao MX, Wang JJ, Zhou YB, Han Y, Chen Q, Li YH, et al. 2017. NLRP3 inflammasome activation contributes to VSMC phenotypic transformation and proliferation in hypertension. Cell Death Dis. 8(10):e3074.
   PubMedGoogle Scholar
• Sun Y, Lu M, Sun T, Wang H. 2021. Astragaloside IV attenuates inflammatory response mediated by NLRP-3/calpain-1 is involved in the development of pulmonary hypertension. J Cell Mol Med. 25(1):586–590.
   PubMed Web of Science ®Google Scholar
• Tang B, Chen GX, Liang MY, Yao JP, Wu ZK. 2015. Ellagic acid prevents monocrotaline-induced pulmonary artery hypertension via inhibiting NLRP3 inflammasome activation in rats. Int J Cardiol. 180:134–141.
   PubMed Web of Science ®Google Scholar
• Tian X, Zhao X, Liu D, Zhang Y, Qu L, Wu P, He L. 2018. Effect of chloroquine in angiotensin II induced vascular remodeling in mice. J Clin Pathol Res. 38:1595–1600.
   Google Scholar
• Vanhoutte PM, Shimokawa H, Tang EH, Feletou M. 2009. Endothelial dysfunction and vascular disease. Acta Physiol. 196(2):193–222.
   PubMed Web of Science ®Google Scholar
• Wang R, Liu L, Liu H, Wu K, Liu Y, Bai L, Wang Q, Qi B, Qi B, Zhang L. 2019. Reduced NRF2 expression suppresses endothelial progenitor cell function and induces senescence during aging. Aging (Albany NY). 11(17):7021–7035.
   PubMedGoogle Scholar
• Whiteford JR, D, Rossi G, Woodfin A. 2016. Mutually supportive mechanisms of inflammation and vascular remodeling. Int Rev Cell Mol Biol. 326:201–278.
   PubMed Web of Science ®Google Scholar
• Xue Z, Li Y, Zhou M, Liu Z, Fan G, Wang X, Zhu Y, Yang J. 2021. Traditional herbal medicine discovery for the treatment and prevention of pulmonary arterial hypertension. Front Pharmacol. 12:720873.
   PubMed Web of Science ®Google Scholar
• Yue G, Mo L, Luo Y. 2010. Effect of Yiqihuoxuejiedu decoction on inflammatory factor and von Willebrand factor of spontaneously hypertensive pressure rats. J Emerg Tradit Chin Med. 19:1365–1367.
   Google Scholar
• Zhang Z, Yue G. 2012. Protective effects of Yiqi Huoxue Jiedu recipe on the function of blood vessel endothelium in spontaneous hypertension rats. China Pharmacy. 23:200–202.
   Google Scholar
• Zhao N, Yang FE, Zhao CY, Lv SW, Wang J, Liu JM, Wang S. 2021. Construction of pH-dependent nanozymes with oxygen vacancies as the high-efficient reactive oxygen species scavenger for oral-administrated anti-inflammatory therapy. Adv Healthc Mater. 10(23):e2101618.
   PubMed Web of Science ®Google Scholar
• Zhao ZQ, Zhang BL, Chu HQ, Liang L, Chen BZ, Zheng H, Guo XD. 2022. A high-dosage microneedle for programmable lidocaine delivery and enhanced local long-lasting analgesia. Biomater Adv. 133:112620.
   PubMedGoogle Scholar
• Zhou R, Yazdi AS, Menu P, Tschopp J. 2011. A role for mitochondria in NLRP3 inflammasome activation. Nature. 469(7329):221–225.
   PubMed Web of Science ®Google Scholar
• Zhou W, Chen C, Chen Z, Liu L, Jiang J, Wu Z, Zhao M, Chen Y. 2018. NLRP3: a novel mediator in cardiovascular disease. J Immunol Res. 2018:5702103.
   PubMed Web of Science ®Google Scholar